GCNT2 Gene Cataract Autosomal Dominant Genetic Test
At DNA Labs UAE, we offer the GCNT2 Gene Cataract Autosomal Dominant Genetic Test for individuals who suspect they may be at risk for this condition. Our comprehensive test provides valuable insights into the genetic factors that contribute to autosomal dominant cataracts.
Test Details
The GCNT2 gene is associated with autosomal dominant cataracts, a type of cataract inherited from one parent who carries the mutated gene. The GCNT2 gene plays a crucial role in the production of glycoproteins, which are proteins with sugar molecules attached to them. These glycoproteins are essential for cell signaling, adhesion, and immune system function.
Changes or mutations in the GCNT2 gene can affect the structure and function of the beta-1,3-N-acetylglucosaminyltransferase enzyme, leading to disruptions in the production of glycoproteins. This disruption can interfere with the normal development and maintenance of the lens in the eye, resulting in the formation of cataracts.
Method
We utilize NGS (next-generation sequencing) technology for our GCNT2 Gene Cataract Autosomal Dominant Genetic Test. This advanced genetic testing method involves analyzing the DNA sequence of the GCNT2 gene to identify any mutations or changes that may be present.
Components and Price
- Test Name: GCNT2 Gene Cataract Autosomal Dominant Genetic Test
- Components: Blood or Extracted DNA or One drop Blood on FTA Card
- Price: 4400.0 AED
Sample Condition and Report Delivery
We accept blood samples or extracted DNA for this test. Additionally, we also accept one drop of blood on an FTA card. The report delivery time is approximately 3 to 4 weeks.
Test Type and Doctor
The GCNT2 Gene Cataract Autosomal Dominant Genetic Test falls under the category of Ophthalmology Disorders. Our highly qualified Ophthalmologists oversee this test to ensure accurate results.
Test Department and Pre Test Information
This test is conducted in our Genetics department. Prior to the test, it is essential to provide the clinical history of the patient who is undergoing the GCNT2 Gene Cataract Autosomal Dominant NGS Genetic DNA Test. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected by GCNT2 Gene Cataract Autosomal Dominant NGS Genetic DNA Test gene GCNT2.
Benefits of GCNT2 Gene Cataract Autosomal Dominant Genetic Test
- Diagnosis of autosomal dominant cataracts
- Prediction of the risk of developing cataracts in family members
- Genetic counseling and guidance for affected individuals and their families
By undergoing the GCNT2 Gene Cataract Autosomal Dominant Genetic Test, individuals can gain valuable insights into their genetic predisposition for this condition. This knowledge allows for early detection, proactive management, and informed decision-making.
Don’t wait until it’s too late. Take control of your eye health today with DNA Labs UAE’s GCNT2 Gene Cataract Autosomal Dominant Genetic Test.
| Test Name | GCNT2 Gene Cataract autosomal dominant Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ophthalmology Disorders |
| Doctor | Ophthalmologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for GCNT2 Gene Cataract, autosomal dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GCNT2 Gene Cataract, autosomal dominant NGS Genetic DNA Test gene GCNT2 |
| Test Details | The GCNT2 gene is associated with autosomal dominant cataracts, which is a type of cataract that is inherited from one parent who carries the mutated gene. The GCNT2 gene provides instructions for making an enzyme called beta-1,3-N-acetylglucosaminyltransferase, which is involved in the production of glycoproteins. Glycoproteins are proteins that have sugar molecules attached to them, and they play important roles in cell signaling, cell adhesion, and immune system function. Mutations in the GCNT2 gene can lead to changes in the structure or function of the beta-1,3-N-acetylglucosaminyltransferase enzyme, which can affect the production of glycoproteins. This can disrupt the normal development and maintenance of the lens in the eye, leading to the formation of cataracts. NGS (next-generation sequencing) genetic testing can be used to identify mutations in the GCNT2 gene that are associated with autosomal dominant cataracts. This type of genetic testing involves analyzing the DNA sequence of the gene to identify any changes or mutations that may be present. This information can be used to diagnose the condition, predict the risk of developing cataracts in family members, and provide genetic counseling and guidance for affected individuals and their families. |
